This $30B Cement Powerhouse Could Break the Growth Mold—Here’s Why Wall Street is Taking Note
Why a boring spin-off from Holcim might be the under-the-radar growth play of the year—with analysts calling for +20% upside.
Every market cycle reveals a hidden giant—something boring, overlooked, and unreasonably cheap. That’s where real wealth is made.
Amrize Ltd (NYSE: AMRZ) is exactly that. A freshly minted spin-off from Holcim, it owns the last major cement plant built in the U.S., dominates key regional markets, and is projected to throw off $8 billion in free cash flow over the next four years. It’s capital-efficient, moat-protected, and trading below peer multiples.
Most investors haven’t caught on yet. But the big players are circling. Wall Street is waking up. And once this flywheel starts spinning, there’s no turning back.
Let’s dive in.
YTD Performance Snapshot
Stock Price (as of July 9, 2025): $51.29
Market Cap: ~$28.5 billion
YTD Performance: Flat (listed June 2025)
Peer Comparison: Trades at a discount to Martin Marietta and Vulcan Materials, with EV/EBITDA around 10x vs. peer averages near 14–15x
Sector Position: Largest cement producer in the U.S. and top 1–2 aggregate player in 85% of served markets
Bear Case: What Could Go Wrong
Let’s face it—there are reasons spin-offs get discounted at first. Here’s where the risks lie:
